ELUT
ELUTIA INC.Company Information
- Company Name
- ELUTIA INC.
- CIK
- CIK0001708527
- Category
- <br>Emerging growth company
- Ticker: Exchange
- ELUT: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- ELUT
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-01-30
- Last sale
- 2023-03-09
- Shares purchased (TTM)
- 1,135,000
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 14,315,873
- Shares outstanding
- 44,223,722
- Ownership
- 32.37%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- -12.75%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 20 | 28 | 36 | 5 | 9 | 17 | 13 | 26 | 18 | 13 | 19 | 15 | ||||||
| Accounts Receivable Net Current | 1 | 2 | 2 | 4 | 3 | 3 | 2 | 3 | 4 | 4 | 3 | 3 | ||||||
| Inventory Net | 3 | 3 | 3 | 2 | 5 | 4 | 2 | 4 | 3 | 3 | 4 | 7 | ||||||
| Loss Contingency Receivable Current | 4 | 5 | 5 | 5 | 4 | 4 | 5 | 5 | 4 | 2 | 3 | 7 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 2 | 2 | 1 | 1 | 2 | 2 | 0 | 1 | 2 | 2 | 0 | ||||||
| Assets Of Disposal Group Including Discontinued Operation Current | - | - | - | 3 | - | - | 2 | - | - | - | - | 7 | ||||||
| Assets Current | 37 | 49 | 56 | 18 | 22 | 30 | 26 | 37 | 30 | 24 | 31 | 39 | ||||||
| Property Plant And Equipment Net | 3 | 3 | 3 | 2 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | ||||||
| Intangible Assets Net Excluding Goodwill | 1 | 1 | 2 | 2 | 7 | 7 | 3 | 9 | 10 | 11 | 12 | 13 | ||||||
| Other Assets Noncurrent | 3 | 2 | 2 | 3 | 3 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | ||||||
| Disposal Group Including Discontinued Operation Assets Noncurrent | - | - | - | 5 | - | - | 7 | - | - | - | - | 3 | ||||||
| Assets | 44 | 55 | 62 | 29 | 34 | 39 | 36 | 48 | 42 | 35 | 43 | 55 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 4 | 4 | 5 | 7 | 6 | 5 | 4 | 5 | 3 | 4 | 3 | 3 | ||||||
| Accrued Liabilities Current | 5 | 6 | 4 | 7 | 6 | 6 | 7 | 5 | 7 | 9 | 9 | 11 | ||||||
| Short Term Borrowings | - | - | - | 5 | 4 | 3 | 1 | - | 3 | 2 | 3 | - | ||||||
| Litigation Reserve Current | 6 | 8 | 11 | 16 | 17 | 18 | 20 | 24 | 20 | 16 | 15 | 16 | ||||||
| Other Liabilities Current | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Current | - | - | - | 0 | - | - | 0 | - | - | - | - | 3 | ||||||
| Liabilities Current | 21 | 24 | 25 | 41 | 38 | 37 | 38 | 40 | 40 | 38 | 43 | 45 | ||||||
| Long Term Debt Noncurrent | - | - | - | 21 | 21 | 22 | 23 | 23 | 19 | 20 | 20 | 25 | ||||||
| Warrants And Rights Outstanding | 3 | 3 | 3 | 4 | 9 | 12 | 16 | 19 | 39 | 20 | 13 | 8 | ||||||
| Other Liabilities Noncurrent | - | - | - | - | - | - | - | 2 | 2 | 1 | 1 | 0 | ||||||
| Operating Lease Liability Noncurrent | 4 | 4 | 4 | 3 | 3 | 0 | 0 | - | - | - | - | - | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Noncurrent | - | - | - | 0 | - | - | 0 | - | - | - | - | 1 | ||||||
| Liabilities | 28 | 33 | 35 | 73 | 76 | 76 | 82 | 89 | 106 | 86 | 82 | 84 | ||||||
Stockholders Equity | ||||||||||||||||||
| Additional Paid In Capital | 207 | 206 | 204 | 203 | 201 | 197 | 183 | 180 | 157 | 143 | 137 | 137 | ||||||
| Retained Earnings Accumulated Deficit | -191 | -184 | -176 | -247 | -243 | -234 | -230 | -221 | -222 | -194 | -176 | -166 | ||||||
| Stockholders Equity | 16 | 23 | 28 | -44 | -42 | -36 | -46 | -40 | -64 | -50 | -39 | -29 | ||||||
| Liabilities And Stockholders Equity | 44 | 55 | 62 | 29 | 34 | 39 | 36 | 48 | 42 | 35 | 43 | 55 | ||||||
| Notes And Loans Receivable Net Current | - | - | - | - | - | - | - | - | - | - | - | 1 | ||||||
| Common Class A | 0 | 44 | 43 | 2 | 2 | 37 | 31 | 6 | 24 | -4 | 19 | 7 | ||||||
| Common Class B | 0 | 0 | 0 | -2 | 0 | 4 | 4 | 0 | 4 | 0 | 4 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialELUTIA INC. (ELUT) — SEC Financial Statements & Analysis
ELUTIA INC. (ELUT) is a biological products, (no diagnostic substances) company, incorporated in DE. ELUTIA INC. trades on Nasdaq as: ELUT. ELUTIA INC. (ELUT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, ELUTIA INC. carries a market cap of $43.34M, a P/E ratio of 0.84x, a P/B ratio of 2.75x, a P/S ratio of 3.57x, an enterprise value of $23.44M, and an EV/EBITDA multiple of -0.96x. On profitability, it posts a gross margin of 57.76%, an operating margin of -214.85%, a net margin of 426.90%, a Return on Equity (ROE) of -397.04%, and a Return on Assets (ROA) of 133.70%. Per share, it reports EPS of $1.17, diluted EPS of $1.17, free cash flow per share of $-1.04, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 69.03% year-over-year, net income growth of -343.02% year-over-year, and EPS growth of -329.61% year-over-year. On the balance sheet, it maintains a current ratio of 1.77x, a quick ratio of 1.58x, working capital of $16.17M, a debt-to-equity ratio of 1.77x, a debt ratio of 0.64, an interest coverage ratio of -63.91x, free cash flow of $-46.03M (TTM), and net debt of $-19.90M. Figures sourced from SEC EDGAR.
- Market Cap
- $43.34M
- P/E TTM
- 0.84x
- EPS TTM
- $1.17
- P/B TTM
- 2.75x
- ROE TTM
- -397.04%
- ROA TTM
- 133.70%
- Debt To Equity
- 1.77x
- Free Cash Flow TTM
- $-46.03M
- Net Revenue TTM Growth 1Y
- 69.03%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ELUTIA INC. in?
ELUTIA INC. (ELUT) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does ELUT trade on?
ELUTIA INC. (ELUT) trades on the Nasdaq.
Where is ELUTIA INC. incorporated?
ELUTIA INC. is incorporated in DE.
When was ELUTIA INC. (ELUT)'s most recent SEC filing?
ELUTIA INC. (ELUT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is ELUT's market cap?
ELUTIA INC. (ELUT) has a market capitalization of $43.34M as of 2026-06-30.
What is ELUT's P/E ratio?
ELUTIA INC. (ELUT)'s trailing twelve month P/E ratio is 0.84x as of 2026-06-30.
What is ELUT's EPS (earnings per share)?
ELUTIA INC. (ELUT)'s trailing twelve month EPS is $1.17 as of 2026-06-30.
What is ELUT's ROE (return on equity)?
ELUTIA INC. (ELUT)'s trailing twelve month Return on Equity (ROE) is -397.04% as of 2026-06-30.
What is ELUT's ROA (return on assets)?
ELUTIA INC. (ELUT)'s trailing twelve month Return on Assets (ROA) is 133.70% as of 2026-06-30.
What is ELUT's EV/EBITDA?
ELUTIA INC. (ELUT)'s trailing twelve month EV/EBITDA is -0.96x as of 2026-06-30.